Compare FTLF & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FTLF | ORMP |
|---|---|---|
| Founded | 2005 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 154.6M | 134.1M |
| IPO Year | 2006 | 2010 |
| Metric | FTLF | ORMP |
|---|---|---|
| Price | $14.50 | $3.25 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $23.00 | N/A |
| AVG Volume (30 Days) | 13.8K | ★ 164.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.61% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.47 | ★ 1.26 |
| Revenue | ★ $21,744,000.00 | $1,340,000.00 |
| Revenue This Year | $32.74 | N/A |
| Revenue Next Year | $50.36 | N/A |
| P/E Ratio | $31.27 | ★ $2.61 |
| Revenue Growth | ★ 11.52 | N/A |
| 52 Week Low | $9.83 | $1.82 |
| 52 Week High | $20.98 | $3.76 |
| Indicator | FTLF | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 41.96 | 47.00 |
| Support Level | $12.25 | $3.22 |
| Resistance Level | $15.31 | $3.76 |
| Average True Range (ATR) | 0.41 | 0.21 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 47.61 | 22.22 |
FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Isatori, and Biogenetic laboratories brand names. Its product portfolio consists of sports nutrition, energy, sports drink products, meal replacement products, and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care and Household Products, and Supplements.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.